iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
1. IRTC's Q3 loss of 6 cents beats expectations of a 31-cent loss. 2. Sales reached $192.88 million, exceeding the $184.74 million consensus. 3. Raised fiscal 2025 sales guidance to $735-$740 million, above $726.42 million consensus. 4. Strong demand for Zio AT drives revenue and gross profit increase. 5. Analysts maintain Buy ratings, with price forecasts raised significantly.